CompletedNCT05610072
Glutamate, NAC, and opioid and cocaine use
About this title
Read the official source — NCT05610072Medication studyAges 18–55United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 55 years.
- Listed locations
- Lexington and 1 more locationSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Study information
Study start dateStarted: December 15, 2022
- Recruitment status
- Completed
- Enrollment listed in the registry
- 12
- Sponsor
- William Stoops
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT05610072
- Official title
Show the full official title
Glutamatergic Mechanisms in Opioid and Cocaine Co-Use
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Lexington
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is William Stoops.
Did this study involve medication?
Yes. The study involved medication, including n-acetylcysteine, Hydromorphone, Placebo n-acetylcystine and Placebo hydromorphone.
Who was this study for?
Listed age limits: 18 years to 55 years.
